SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-303989
Filing Date
2021-10-21
Accepted
2021-10-21 16:06:08
Documents
14
Period of Report
2021-10-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d246715d8k.htm   iXBRL 8-K 23692
2 EX-99.1 d246715dex991.htm EX-99.1 19830
6 GRAPHIC g246715g1021223632070.jpg GRAPHIC 2440
  Complete submission text file 0001193125-21-303989.txt   173477

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cydy-20211021.xsd EX-101.SCH 2890
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cydy-20211021_lab.xml EX-101.LAB 17425
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cydy-20211021_pre.xml EX-101.PRE 10967
7 EXTRACTED XBRL INSTANCE DOCUMENT d246715d8k_htm.xml XML 3353
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 211337079
SIC: 2834 Pharmaceutical Preparations